Advanced search
Publication Cover
Expert Review of Vaccines Volume 3, 2004 - Issue 6
Submit an article Journal homepage
162
Views
37
CrossRef citations to date
0
Altmetric
Review

Antigen discovery and delivery of subunit vaccines by nonliving bacterial ghost vectors

Petra Walcher University of Vienna, Institute of Microbiology and Genetics, Department Microbiology and Biotechnology, UZA II, 2B255, Althanstrasse 14, A-1090 Wien, Austria
,
Ulrike B Mayr University of Vienna, Institute of Microbiology and Genetics, Department Microbiology and Biotechnology, UZA II, 2B255, Althanstrasse 14, A-1090 Wien, Austria
,
Chakameh Azimpour-Tabrizi University of Vienna, Institute of Microbiology and Genetics, Department Microbiology and Biotechnology, UZA II, 2B255, Althanstrasse 14, A-1090 Wien, Austria
,
Francis O Eko Morehouse School of Medicine, Department of Microbiology, Biochemistry and Immunology, Atlanta, GA, USA
,
Wolfgang Jechlinger University of Veterinary Medicine, Institute of Bacteriology, Mycology and Hygiene, Veterinärplatz 1, A-1210 Vienna, Austria
,
Peter Mayrhofer University of Veterinary Medicine, Institute of Bacteriology, Mycology and Hygiene, Veterinärplatz 1, A-1210 Vienna, Austria
,
Tim Alefantis Vital Probes Ltd, 1300 Old Plank Road, Mayfield PA 18433, USA
,
Cesar V Mujer Vital Probes Ltd, 1300 Old Plank Road, Mayfield PA 18433, USA
,
Vito G DelVecchio Vital Probes Ltd, 1300 Old Plank Road, Mayfield PA 18433, USA
&
Werner Lubitz University of Vienna, Institute of Microbiology and Genetics, Department Microbiology and Biotechnology, UZA II, 2B255, Althanstrasse 14, A-1090 Wien, Austria. [email protected]
 show all
Pages 681-691 | Published online: 09 Jan 2014

References

  • Jechlinger W, Haidinger W Paukner S et al. Bacterial ghosts as carrier and targeting systems for antigen delivery. In: Vaccine Delivery Strategies. Dietrich G, Goebel W (Eds). Horizon Scientific Press, Wymondham, UK, 163–184 (2002).
  • Eko FO, Witte A, Huter V et al. New strategies for combination vaccines based on the extended recombinant bacterial ghost system. Vaccinel7, 1643–1649 (1999).
  • Jechlinger W, Szostak M, Lubitz W. Cold- sensitive E-lysis systems. Gene 218, 1–7 (1998).
  • Jechlinger W, Szostak MP, Witte A, Lubitz W. Altered temperature induction sensitivity of the lambda PR/cI857 system for controlled gene E-expression in Escherichia colt FEMS Microbiol. Lett. 173, 347–352 (1999).
  • Jechlinger W, Clocker J, Haidinger W et al. Modulation of gene expression by promoter mutants of the lambda pRic1857 system. J Biotechnol. (2004). In Press.
  • •Novel system for temperature-induced gene expression.
  • Haidinger W, Mayr UB, Szostak M, Resch S, Lubitz W. Escherichia coli ghost production by expression of lysis gene E and staphylococcal nuclease. App]. Envr. Microbiol. 69,6106–6113 (2003).
  • Haidinger W Szostak Jechlinger, M. Lubitz, W. W. Online monitoring of the Escherichia coil ghost production. App]. Envr. Microbiol. 69,468–474 (2003).
  • Riedmann EM, Kyd JM, Cripps AW, Lubitz W Adjuvant properties of bacterial ghosts. Vaccine (2004). In Press.
  • Haslberger A, Kohl G, Felnerova D et al. Activation, stimulation and uptake of bacterial ghosts in antigen-presenting cells. Biotechnol. 83,57–66 (2000).
  • Kudela P, Paukner S, Mayr UB et al. Bacterial ghosts as novel efficient targeting vehicles for DNA delivery to the human monocytes-derived dendritic cell. J Irnmunother. (2004). In Press.
  • Felnerova D, Kudela P, Bizik J et al. T-cell specific immune response induced by bacterial ghosts. Med. Sc. Monitor 10, 362–370 (2004).
  • Eko FO, Hensel A, Bunka S, Lubitz W Immunogenicity of Vibrio cholerae ghosts following intraperitoneal immunization of mice. Vaccine 12,1330–1334 (1994).
  • Eko FO, Mayr UB, Attridge SR, Lubitz W. Characterization and immunogenicity of Vibrio cholerae ghosts expressing toxin-coregulated ph. j Biotechnol. 83,115–123 (2000).
  • Eko FO, Schukovskaya T, Lotzmanova LY et al. Evaluation of the protective efficacy of Vibrio cholerae ghost (VCC) candidate vaccines in rabbits. Vaccine 21,3663–3674 (2003).
  • Huter V, Hensel A, Brand E, Lubitz W. Improved protection against lung colonization by Actinobacillus pleuropneurnoniae ghosts: characterization of a genetically inactivated vaccine. J Biotechnol. 83,161–172 (2000).
  • Hensel A, Huter V, Katinger A et al. Intramuscular immunization with genetically inactivated (ghosts) Actinobacillus pleuropneurnoniae serotype 9 protects pigs against homologous aerosol challenge and prevents carrier state. Vaccine 18,2945–2955 (2000).
  • Katinger A, Lubitz W, Szostak MP et al. Pigs aerogenously immunized with genetically inactivated (ghosts) or irradiated Actinobacillus pleuropneurnoniae are protected against a homologous aerosol challenge despite differing in pulmonary cellular and antibody responses. J Biotech. 73, 251–260 (1999).
  • Hensel A, van Leengoed LAG, Szostak M et al. Induction of protective immunity by aerosol or oral application of candidate vaccines in a dose-controlled pig aerosol infection model. Biotechria 44,171–181 (1996).
  • Panthel K, Jechlinger W, Matis A et al. Generation of Helicobacter pylori ghosts by PhiX protein E-mediated inactivation and their evaluation as vaccine candidates. Infect. II771771117. 71,109–116 (2003).
  • Marchart J, Rehagen M, Dropmann G et al Protective immunity against Pasteurellosis in cattle, induced by Pasteurella haernolytica ghosts. Vaccine21,1415–1422 (2003).
  • Marchart J, Dropmann G, Lechleitner S et al. Pasteurella multocida- and Pasteurella haernolytica-ghosts: new vaccine candidates. Vaccine 21,3988–3997 (2003).
  • Szostak MP, Hensel A, Eko FO et al. Bacterial ghosts: nonliving candidate vaccines. J Biotechnol. 44,161–170 (1996).
  • Eko FO, Lubitz W, Mcmillan L et al. Recombinant Vibrio cholerae ghosts as a delivery vehicle for vaccinating against Chlarnydia trachornatis. Vaccine 21, 1694–1703 (2003).
  • Eko FO, He Q, Brown T et al. A novel recombinant multisubunit vaccine against Chlanydia. j II77177111701. 173,3375–3382 (2004).
  • Eko FO, Ifere GO, He Q et al. Enhanced immune responses and protection by a MOMP/PorB multisubunit vaccine. J lininunol. Submitted (2004).
  • Riedmann E, Kyd J, Smith A et al. Contruction of recombinant S-layer proteins (rSbsA) and their expression in bacterial ghosts — a delivery system for the nontypeable Haernophilus iniluenzae antigen Omp26. FEMS km.171117°1. Med. Microbiol. 37,185-192 (2003).
  • Riedmann EM, Lubitz W, Smith AM et al. Immune responses to the nontypeable Haernophilus influenzae antigen Omp26 delivered mucosally in bacterial ghosts. Infect. Irnmun. Submitted (2004).
  • Jechlinger W, Haller C, Resch S et al. Comparative immunogenicity of the hepatitis B virus core 149 antigen displayed on the inner and outer membrane of bacterial ghosts. Vaccine (2004). In press.
  • Ebensen T, Paukner S, Link C et al. Bacterial ghosts are an efficient delivery system for DNA vaccines. J Innnunol. 172, 6858–6865 (2004).
  • Mader HJ, Szostak MP, Hensel A, Lubitz W, Haslberger AG. Endotoxicity does not limit the use of bacterial ghosts as candidate vaccine. Vaccine 15, 195–202 (1997).
  • Huter V, Szostak MP, Gampfer J et al. Bacterial ghosts as drug carrier and targeting vehicles. J Control. Release 61, 51–63 (1999).
  • ••First report of filling bacterial ghosts.
  • Kuen B, Sara M, Lubitz W. Heterologous expression and self-assembly of the S-layer protein SbsA of Bacillus stearotherrnophilus in Ercherichia coll. Ma Microbiol. 19, 495–503 (1995).
  • Kuen B, Koch A, Asenbauer E, Sara M, Lubitz W Molecular characterization of the Bacillus stearotherrnophilus PV72 S-layer gene sbsB induced by oxidative stress. J Bacteria 179, 1664–1670 (1997).
  • Truppe M, Horworka S, Schroll G et al. Biotechnological applications of recombinant S-layer proteins rSbsA and rSbsB from Bacillus stearotherrnophilus PV72. FEMS Microbia Rev. 20, 88–98 (1997).
  • Paukner S, Kohl G, Jalava J, Lubitz W. Sealed bacterial ghosts-novel targeting vehicles for advanced drug delivery of water-soluble substances. J Drug Target. 11, 151–161 (2003).
  • Mayr UB, Walcher P, Azimpour C et al. Bacterial ghosts as delivery vehicles for vaccination against target antigens. Adv Drug Deily. Rev (2004). In Press.
  • Paukner S, Kudela P, Kohl G et al. DNA-loaded bacterial ghosts efficiently mediate reporter gene transfer and expression in macrophages. Ma Ther. (2004). In Press.
  • Mayrhofer P, Azimpour Tabrizi C, Walcher P et al. Immobilization of plasmid DNA in bacterial ghosts. J Control. Release (2004). In Press.
  • Wilkins MR, Sanchez JC, Cooley AA et al. Progress with proteome projects: why all proteins expressed by a genome should be identified and how to do it. Biotecnol. Genet. Eng. Rev 13, 19–50 (1996).
  • Liebler DC. Introduction to Proteornics: Tools for the New Biology Humana Press, Inc. Totowa, NJ, USA (2002).
  • DelVecchio VG, Wagner MA, Eschenbrenner M et al. Brucella proteomes —a review. Vet. Microbiol. 90, 581–591 (2002).
  • Eschenbrenner M, Wagner MA, Horn TA et al. Comparative analysis of Brucella rnelitensis vaccine strain Rev 1 and a virulent strain 16M. J Bacteria 184, 4962–4970 (2002).
  • Wagner MA, Eschenbrenner M, Horn TA et al. Global analysis of the Brucella rnelitensis proteome: identification of proteins expressed in laboratory-grown culture. Proteornics 2, 1047–1060 (2002).
  • Klade CS. Proteomics approaches towards antigen discovery and vaccine development. Carr. Opin. Ma Ther. 4, 216–223 (2002).
  • Patra G, Williams LE, Dwyer KG, DelVecchio VG. Bacillus anthracis secretome. In: Applications of Genornics and Proteornics for Analysis of Bacterial Biological Warfare Agents. DelVecchio VG, Krcmery V (Eds). IOS Press, Amsterdam, Holland, 53–66 (2002).
  • Ariel N, Zvi A, Maltarova KS et al. Genome- based bioinformatics selection of chromosomal Badllus anthracis putative vaccine candidates coupled with proteomic identification of surface-associated antigens. Infect. II771771117. 71, 4563–4579 (2003).

Websites

  • Matrix Science Ltd www.matrixscience.com (Accessed November, 2004).
  • Duckworth J, Mate K, Scobie S et al. Evaluating Zona pellucida antigens and delivery systems for possum fertility control in New Zealand — progress and future directions (2002). www.maf.goyt.nzimafnethural-nziresearch-and-development (Accessed November, 2004).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.